Securities code: 688089 securities abbreviation: Cabio Biotech (Wuhan) Co.Ltd(688089) Announcement No.: 2022-010
Cabio Biotech (Wuhan) Co.Ltd(688089) Biotechnology (Wuhan) Co., Ltd
Notice of the board of supervisors on the company’s restricted stock incentive plan in 2022
Verification opinions and publicity of the list of incentive objects
The board of supervisors and all supervisors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and completeness of its contents.
Cabio Biotech (Wuhan) Co.Ltd(688089) Biotechnology (Wuhan) Co., Ltd. (hereinafter referred to as “the company”) held the second meeting of the third board of directors and the second meeting of the third board of supervisors on January 17, 2022, deliberated and adopted the proposal on the company’s restricted stock incentive plan (Draft) in 2022 and its summary and other relevant proposals. According to the relevant provisions of the measures for the administration of equity incentive of listed companies (hereinafter referred to as the “measures”), the company publicized the list of some incentive objects first granted by the restricted stock incentive plan in 2022 within the company. The board of supervisors of the company checked the proposed incentive objects in combination with the publicity. The relevant publicity and verification are as follows:
1、 Publicity
1. The company was posted on the website of Shanghai Stock Exchange (www.sse. Com. CN.) on January 18, 2022 It disclosed the 2022 restricted stock incentive plan (Draft) of Cabio Biotech (Wuhan) Co.Ltd(688089) Biotechnology (Wuhan) Co., Ltd. (hereinafter referred to as the “incentive plan (Draft)” and its abstract, and the measures for the administration of the implementation and assessment of the 2022 restricted stock incentive plan of Cabio Biotech (Wuhan) Co.Ltd(688089) Biotechnology (Wuhan) Co., Ltd.
2. From January 18, 2022 to January 27, 2022, the company publicized the names and positions of the proposed incentive objects within the company. The publicity period is 10 days in total. The employees of the company can put forward opinions to the board of supervisors of the company.
As of the expiration of the publicity period, the board of supervisors of the company has not received any objection to the proposed incentive object. 2、 Verification opinions of the board of supervisors
In accordance with the provisions of the management measures and the incentive plan (Draft), the board of supervisors checked the list of some incentive objects first granted under the restricted stock incentive plan in 2022, and issued the following verification opinions:
1. The personnel listed in the list of incentive objects of this incentive plan have the qualifications specified in the company law of the people’s Republic of China (hereinafter referred to as the “company law”), the articles of association of Cabio Biotech (Wuhan) Co.Ltd(688089) Biotechnology (Wuhan) Co., Ltd. (hereinafter referred to as the “articles of Association”) and other laws, regulations and normative documents.
2. The incentive object does not have the situation that it is not allowed to become the incentive object as stipulated in the management measures:
(1) Being identified as an inappropriate candidate by the stock exchange within the last 12 months;
(2) In the last 12 months, it has been identified as an inappropriate candidate by the CSRC and its dispatched offices;
(3) Being administratively punished by the CSRC and its dispatched offices or taking market entry prohibition measures for major violations of laws and regulations in the last 12 months;
(4) Those who are not allowed to serve as directors or senior managers of the company as stipulated in the company law;
(5) Those who are not allowed to participate in the equity incentive of listed companies according to laws and regulations;
(6) Other circumstances recognized by the CSRC.
3. The personnel listed in the list of incentive objects of this incentive plan meet the incentive object conditions specified in the administrative measures, the Listing Rules of science and Innovation Board of Shanghai Stock Exchange and other documents, and meet the incentive object conditions specified in the incentive plan (Draft). The incentive objects granted for the first time in this incentive plan do not include the company’s supervisors and independent directors.
In conclusion, the board of supervisors of the company believes that the personnel listed in the list of some incentive objects granted for the first time in this incentive plan meet the conditions specified in relevant laws, regulations and normative documents and the incentive object conditions specified in the incentive plan (Draft), and they are legal and effective as the incentive objects of this restricted stock incentive plan. It is hereby announced.
Cabio Biotech (Wuhan) Co.Ltd(688089) board of supervisors of Biotechnology (Wuhan) Co., Ltd. February 11, 2022
